153 related articles for article (PubMed ID: 8578811)
1. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
Kallel H; Jouini A; Majoul S; Rourou S
J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.
Merten OW; Kierulff JV; Castignolles N; Perrin P
Cytotechnology; 1994; 14(1):47-59. PubMed ID: 7765112
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
Rourou S; Ben Zakkour M; Kallel H
Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
[TBL] [Abstract][Full Text] [Related]
5. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
[TBL] [Abstract][Full Text] [Related]
6. Vero-cell rabies vaccine produced using serum-free medium.
Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
[TBL] [Abstract][Full Text] [Related]
7. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
Kallel H; Rourou S; Majoul S; Loukil H
Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
[TBL] [Abstract][Full Text] [Related]
8. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
9. Inactivated rabies vaccine produced from the Flury LEP strain of virus grown in BHK-21 suspension cells.
Chapman WG; Ramshaw IA; Crick J
Appl Microbiol; 1973 Dec; 26(6):858-62. PubMed ID: 4588193
[TBL] [Abstract][Full Text] [Related]
10. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
[TBL] [Abstract][Full Text] [Related]
11. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
Pay TW; Boge A; Menard FJ; Radlett PJ
Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
[TBL] [Abstract][Full Text] [Related]
12. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
[TBL] [Abstract][Full Text] [Related]
13. Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX.
Trabelsi K; Zakour MB; Jordan I; Sandig V; Rourou S; Kallel H
BMC Biotechnol; 2022 Jun; 22(1):17. PubMed ID: 35715843
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
[TBL] [Abstract][Full Text] [Related]
15. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
[TBL] [Abstract][Full Text] [Related]
16. Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor.
Gallegos Gallegos RM; Espinosa Larios EL; Ramos Ramírez L; Kretschmer Schmid R; Aguilar Setién A
Arch Med Res; 1995; 26(1):59-63. PubMed ID: 7711449
[TBL] [Abstract][Full Text] [Related]
17. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
[TBL] [Abstract][Full Text] [Related]
18. The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.
Merten OW; Kallel H; Manuguerra JC; Tardy-Panit M; Crainic R; Delpeyroux F; Van der Werf S; Perrin P
Cytotechnology; 1999 Jul; 30(1-3):191-201. PubMed ID: 19003369
[TBL] [Abstract][Full Text] [Related]
19. Studies on pathogenic, immunogenic, and protective efficiency of fox rabies virus before and after adaptation to cell culture: application to vaccination against rabies.
Blancou J; Aubert MF; Andral L
Can J Microbiol; 1983 Jan; 29(1):77-83. PubMed ID: 6831313
[TBL] [Abstract][Full Text] [Related]
20. Purification of rabies virus produced in Vero cells grown in serum free medium.
Trabelsi K; Ben Zakour M; Kallel H
Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
